Liverpool School of Tropical Medicine LSTM researchers are part of a cross-European study to generate new antiviral approaches for emerging diseases and contribute to pandemic preparedness. Their findings will help to develop new antiviral treatments for the disease.
Yet, our understanding of how these infect human cells is still limited. Generating and translating this knowledge into antiviral strategies that benefit affected populations is key. The research will focus on highly pathogenic viruses such as Nipah and Lassa and mosquito-borne viruses like Zika, dengue, yellow fever and chikungunya. Researchers will identify genes within the host that play a key role in viral entry, and virus structures that represent potential targets for therapeutic antibodies or nanobodies.
Systematic research into virus-host interactions will be used to develop antivirals to be followed up in clinical trials. We are convinced that we will make a significant contribution to combating future virus outbreaks. Skip to main content. LSTM joins European antiviral research project to boost pandemic preparedness. News article 15 Jan 1, From: Tropical Disease Biology.
